E-LIB Suche - Ergebnisse für: Chittenden, Sarah

1

SOLLID – a single centre study to develop methods to invest..:

Flux, Glenn ; Murray, Iain ; Rushforth, Dominic...
The British Journal of Radiology. 94 (2020) 1119 - p. , 2020

2

Compartmental Model for 223Ra-Dichloride in Patients With M..:

Taprogge, Jan ; Murray, Iain ; Gear, Jonathan...
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 4 - p. 884-892 , 2019

Link: https://doi.org/10.1016/..

3

Standardised quantitative radioiodine SPECT/CT Imaging for ..:

Gregory, Rebecca A ; Murray, Iain ; Gear, Jonathan...
Physics in Medicine & Biology. 64 (2019) 24 - p. 245013 , 2019

Link: https://doi.org/10.1088/..

4

Bone lesion absorbed dose profiles in patients with metasta..:

Denis-Bacelar, Ana M ; Chittenden, Sarah J ; McCready, V Ralph...
The British Journal of Radiology. 91 (2018) 1084 - p. , 2018

Link: https://doi.org/10.1259/..

5

The potential of 223Ra and 18F-fluoride imaging to predict ..:

Murray, Iain ; Chittenden, Sarah J. ; Denis-Bacelar, Ana M....
European Journal of Nuclear Medicine and Molecular Imaging. 44 (2017) 11 - p. 1832-1844 , 2017

Link: https://doi.org/10.1007/..

6

Reply to 'Single high dose versus repeated bone-targeted ra..:

Denis-Bacelar, Ana M. ; Chittenden, Sarah J. ; Dearnaley, David P....
European Journal of Nuclear Medicine and Molecular Imaging. 45 (2017) 3 - p. 515-517 , 2017

Link: https://doi.org/10.1007/..

7

A radiobiological model of metastatic burden reduction for ..:

Denis-Bacelar, Ana M ; Chittenden, Sarah J ; Murray, Iain...
Physics in Medicine and Biology. 62 (2017) 7 - p. 2859-2870 , 2017

Link: https://doi.org/10.1088/..

8

Phase I/II trials of 186Re-HEDP in metastatic castration-re..:

Denis-Bacelar, Ana M. ; Chittenden, Sarah J. ; Dearnaley, David P....
European Journal of Nuclear Medicine and Molecular Imaging. 44 (2016) 4 - p. 620-629 , 2016

Link: https://doi.org/10.1007/..

9

Patient-specific dosimetry for intracavitary 32P-chromic ph..:

Denis-Bacelar, Ana M. ; Romanchikova, Marina ; Chittenden, Sarah...
European Journal of Nuclear Medicine and Molecular Imaging. 40 (2013) 10 - p. 1532-1541 , 2013

Link: https://doi.org/10.1007/..

10

Reply to: Can an undetectable value of TG and a negative ne..:

Flux, Glenn D. ; Haq, Masud ; Chittenden, Sarah J....
European Journal of Nuclear Medicine and Molecular Imaging. 37 (2010) 5 - p. 1041-1042 , 2010

Link: https://doi.org/10.1007/..

11

A dose-effect correlation for radioiodine ablation in diffe..:

Flux, Glenn D. ; Haq, Masud ; Chittenden, Sarah J....
European Journal of Nuclear Medicine and Molecular Imaging. 37 (2009) 2 - p. 270-275 , 2009

Link: https://doi.org/10.1007/..

12

Whole-Body Dosimetry for Targeted Radionuclide Therapy Usin..:

Divoli, Antigoni ; Spinelli, Antonello ; Chittenden, Sarah..
Cancer Biotherapy and Radiopharmaceuticals. 20 (2005) 1 - p. 66-71 , 2005

Link: https://doi.org/10.1089/..

13

Absorbed Dose Ratios for Repeated Therapy of Neuroblastoma ..:

Flux, Glenn D ; Guy, Matt J ; Papavasileiou, Periklis...
Cancer Biotherapy and Radiopharmaceuticals. 18 (2003) 1 - p. 81-87 , 2003

Link: https://doi.org/10.1089/..

14

A model-based method for the prediction of whole-body absor..:

Buffa, Francesca M. ; Flux, Glenn D. ; Guy, Matt J....
European Journal of Nuclear Medicine and Molecular Imaging. 30 (2003) 8 - p. 1114-1124 , 2003

Link: https://doi.org/10.1007/..

15

Bone lesion absorbed dose profiles in patients with metasta..:

Denis-Bacelar, Ana M ; Chittenden, Sarah J ; McCready, V Ralph...
Denis-Bacelar , A M , Chittenden , S J , McCready , V R , Divoli , A , Dearnaley , D P , O'Sullivan , J M , Johnson , B & Flux , G D 2018 , ' Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy ' , British Journal of Radiology , vol. 91 , 20170795 . https://doi.org/10.1259/bjr.20170795. , 2018

Link: https://pure.qub.ac.uk/e..